European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 191-195 , February 2008

Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: A single institution experience with 17 cases

  • F. Sellner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • Corresponding Author InformationCorresponding author. Sozialmedizinisches Zentrum Süd – Kaiser-Franz-Josef-Hospital, Surgical Department, Kundratstrasse 3, A-1100 Wien, Austria. Tel.: +43 (1) 60191 999 4185; fax: +43 (1) 60191 4109.
    • ,
  • B. Sobhian

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • ,
  • M. De Santis

      Affiliations

    • Medical Department III (Oncology), Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • ,
  • J. Pont

      Affiliations

    • Medical Department III (Oncology), Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • ,
  • St. Staettner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • ,
  • St. Sellner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • ,
  • J. Karner

      Affiliations

    • Department of Surgery, Kaiser-Franz-Josef-Hospital, Vienna, Austria
    • ,
  • M. Klimpfinger

      Affiliations

    • Institute of Pathology and Bacteriology, Kaiser-Franz-Josef-Hospital, Vienna, Austria

,Accepted 12 March 2007.

References 

  1. De Lellis R, Lloyd R, Heitz Ph, Eng C. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004;
  2. Solcia E, Kloppel G, Sobin L. WHO histological classification of tumours. Histological typing of endocrine tumours. 2nd ed.. Berlin, Heidelberg, New York, Geneva: Springer Verlag; 2000;
  3. Capella C, Heitz P, Hofler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and lung. Virchows Arch. 1995;425:547–560
  4. Sobin LH, Wittekind Ch. TNM classification of malignant tumours. 6th ed.. New York: John Wiley & Sons; 2002;
  5. Heitz Ph, Komminoth P, Perren A, et al. Pancreatic endocrine tumours: introduction. In:  De Lellis R,  Lloyd R,  Heitz Ph,  Eng C editor. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004;
  6. Dralle H, Krohn S, Karges W, Boehm B, Braukhoff M, Grimm O. Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg. 2004;28:1248–1260
  7. Matthews B, Heniford B, Reardon P, Brunicardi F, Greene F. Surgical experience with non-functioning neuroendocrine tumors of the pancreas. Am Surg. 2000;66:1116–1122
  8. Gullo L, Migliori M, Falconi M, et al. Nonfunctioning endocrine tumors: a multicenter clinical study. Am J Gastroenterol. 2003;98:2435–2439
  9. Schindl M, Kaczirek K, Kaserer K, Niederle B. Is the new classification of neuroendocrine pancreatic tumors of clinical help?. World J Surg. 2000;24:1312–1318
  10. Madura J, Cummings O, Wiebke E, Broadie T, Goulet R, Howard T. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort. Am Surg. 1997;63:573–577
  11. Kouvaraki M, Solorzano C, Shapiro S, et al. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol. 2005;89:170–185
  12. Hellmann P, Anderson M, Rastad J, et al. Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg. 2000;24:1353–1360
  13. Liang H, Wang P, Wang X, Wang J, Hao X. Management of nonfunctioning islet cell tumors. World J Gastroenterol. 2004;10:1806–1809
  14. Solorzano C, Lee J, Pisters P, et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery. 2001;130:1078–1085
  15. Schwab M, Knoll M, Jentschura D, Hagmüller E. Hormone-inactive neuroendocrine tumors of the pancreas. Chirurg. 1997;68:705–709
  16. La Rosa S, Sessa F, Capella C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 1996;429:323–333
  17. Bartsch D, Schilling Th, Ramaswamy A, et al. Management of nonfunctioning islet cell carcinomas. World J Surg. 2000;24:1418–1424
  18. Bordi C, Öberg K, Papotti M, Volante M, Capella C. Poorly differentiated endocrine carcinoma. In:  De Lellis R,  Lloyd R,  Heitz Ph,  Eng C editor. WHO Classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004;
  19. Skogseid B. Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids. World J Surg. 2001;25:700–703
  20. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol. 2001;12(Suppl. 2):111–114
  21. Madeira I, Terris B, Voss M, et al. Prognostic factors in patients with endocrine tumors of the duodenopancreatic area. Gut. 1998;43:422–427
  22. Eriguchi N, Aoyagi S, Hara M, Fukuda S, Tanaka F, Hashimoto M. Nonfunctioning islet cell carcinoma of the pancreas: an evaluation of seven patients who underwent resection followed by long-term survival. Surg Today. 1999;29:233–237
  23. Pivonello R, Ferone D, Filipella M, et al. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors. J Endocrinol Invest. 2003;26:82–88
  24. Ansell S, Pitot H, Burch P, Kvols L, Mahoney M, Rubin J. A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors. Cancer. 2001;91:1543–1548

PII: S0748-7983(07)00136-9

doi: 10.1016/j.ejso.2007.03.008

European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 191-195 , February 2008

Article Tools

* Image Usage & Resolution